THREAD and Amazon Web Services Modernize Clinical Research with Launch of Cloud-based, AI-driven Decentralized Clinical Trials Technology


Hitesh

THREAD®, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today that it is collaborating with Amazon Web Services, Inc. (AWS) to launch enhancements to the THREAD platform powered by enterprise-scale automation and built-in AI-driven technologies. Read More

Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics


Hitesh

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has entered into a definitive agreement to divest Sunosi® (solriamfetol), a dual-acting dopamine and norepinephrine reuptake inhibitor shown to improve wakefulness in adults living with excessive daytime sleepiness (EDS) due to narcolepsy or obstructive sleep apnea (OSA), to Axsome Therapeutics (Nasdaq: […]

Innovent and Lilly Expand Strategic Partnership in Oncology


Hitesh

Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company (“Lilly”,NYSE: LLY) today announced that in light of both parties’ shared commitment to continue bringing innovative medicines […]

Triastek and Siemens announce strategic collaboration to accelerate the digital transformation of the pharmaceutical industry


Hitesh

Triastek, Inc. and Siemens Ltd. have signed a strategic collaboration agreement in China to provide digital technologies to the global pharmaceutical industry. The combination of Triastek’s cutting-edge digital pharmaceutical and 3D printing technologies and Siemens’ global leadership in automation and digitization is expected to lead to innovative and transformative solutions […]